Simpler insulin regimen may work just as well for diabetes

NCT ID NCT05417841

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two ways of taking insulin in people with type 2 diabetes. One group took a mix of long- and fast-acting insulin twice a day. The other group took the mix once a day plus extra fast-acting insulin at meals. After 16 weeks, researchers compared blood sugar control and safety. The goal was to see if the simpler twice-daily schedule is just as effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Insulin degludec and insulin aspart (a mix of long- and fast-acting insulin)
What this could lead to
If successful, this could show that a simpler twice-daily insulin mix works as well as a more complex schedule, making diabetes management easier for patients.
What could go wrong
This is a completed trial with 218 participants, so results are available but not yet widely published. The benefit is about convenience, not a cure, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aerospace general hospital

    Beijing, China

  • Beijing Boai Hospital

    Beijing, China

  • Beijing Hospital

    Beijing, China

  • Hebei General Hospital

    Shijiazhuang, Hebei, China

  • Jilin University Sino-Japanese Friendship Hospital

    Changchun, Jilin, China

  • Peking university shougang hospital

    Beijing, China

  • The Second Affiliated Medical College of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.